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PURPOSE. Scleral cross-linking (SXL) with a photosensitizer and light is a potential strategy to
mechanically reinforce the sclera and prevent progressive axial elongation responsible for
severe myopia. Current approaches for light delivery to the sclera are cumbersome, do not
provide uniform illumination, and only treat a limited area of sclera. To overcome these
challenges, we developed flexible optical waveguides optimized for efficient, homogeneous
light delivery.
METHODS. Waveguides were fabricated from polydimethylsiloxane elastomer. Blue light (445
nm) is coupled into the waveguide with an input fiber. Light delivery efficiency from the
waveguide to scleral tissue was measured and fit to a theoretical model. SXL was performed
on fresh porcine eyes stained with 0.5% riboflavin, using irradiances of 0, 25, and 50 mW/cm2
around the entire equator of the eye. Stiffness of scleral strips was characterized with
tensiometry.
RESULTS. Light delivery with a waveguide of tapered thickness (1.4–0.5 mm) enhanced the
uniformity of light delivery, compared to a flat waveguide, achieving a coefficient of variation
of less than 10%. At 8% strain, sclera cross-linked with the waveguides at 50 mW/cm2 for 30
minutes had a Young’s modulus of 10.7 6 1.0 MPa, compared to 5.9 6 0.5 MPa for no
irradiation, with no difference in stiffness between proximally and distally treated halves. The
stiffness of waveguide-irradiated samples did not differ from direct irradiation at the same
irradiance.
CONCLUSIONS. We developed flexible waveguides for periscleral cross-linking. We demonstrat-
ed efficient and uniform stiffening of a 5-mm-wide equatorial band of scleral tissue.
Keywords: photo–cross-linking, optical waveguide, sclera reinforcement, myopia control
Myopia is a rapidly growing visual disorder, which couldaffect 2.5 billion people—one-third of the world’s
population—by 2020.1 Patients with severe myopia are highly
susceptible to other serious problems such as retinal detach-
ment, glaucoma, and cataract.2 Since the severity of myopia
increases with earlier onset, strategies to control myopia
progression in at-risk children and young patients with high
myopia are of great interest. Although scleral deformities are
thought to be in response to aberrant retinal signaling,
pathologic changes in the sclera have been identified as an
important feature in the early development of myopia and
considered possible targets for preventive therapy. In particular,
studies3–5 have suggested that matrix remodeling of the sclera
plays an active role leading to thinning and biomechanical
weakening of scleral tissue, and subsequent axial lengthening
of the vitreous chamber. A promising strategy to stabilize the
axial length and thereby frustrate myopia development is to
mechanically reinforce the sclera. Surgical reinforcement of the
posterior sclera with mechanically stiffer donor grafts or
artificial biological materials has been performed on patients
with severe myopia with mixed success.6–8 The efficacy of
scleral reinforcement surgeries is controversial, and its use
remains limited outside Russia and China, owing to low
efficacy, high invasiveness, serious complications, and need
for healthy scleral donor tissue.9,10
Corneal collagen cross-linking is a minimally invasive,
successful treatment already adopted in the clinic to arrest
the progression of keratoconus primarily by improving the
mechanical stability of corneal tissues.11 Collagen cross-linking
is an attractive technique for strengthening the sclera to
prevent the progression of pathologic myopia. Light-activated
photosensitizers induce intermolecular cross-links between
neighboring collagen molecules, strengthening the collagen
network and enhancing tissue rigidity. Scleral cross-linking
(SXL) has been demonstrated in several animal models,12–17 as
well as ex vivo human sclera,18 most commonly by using
riboflavin in conjunction with UV-A (360–370 nm) or blue
light. Target regions for SXL treatment include the equatorial
sclera, which is weakened in the early stages of myopia, and the
posterior pole, which is affected later and more dramatically.19
Unlike the cornea, the anatomic shape of the sclera poses
significant technical challenges for photo-mediated cross-
linking. The equatorial sclera spans a long length (6–8 cm)
and is not readily accessible by external laser illumination. A
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light-delivery apparatus must be safely introduced and operat-
ed deep in the eye socket to deliver light to the relatively large
target region with sufficient irradiance. Homogeneous light
distribution around the eye globe is another critical require-
ment for uniform stiffening to prevent asymmetric changes to
eye shape. Previously described approaches for light delivery
typically involve invasive and time-consuming dissection of
surrounding soft tissues, such as attached extraocular muscles,
to expose scleral tissue.20 For example, recent approaches
involve rotating the eye to expose target regions along the
equator,12,13,21 or at the posterior pole,14 to an external light
source or fiber-optic probe. The area of each of these
irradiation zones ranges from 10 to 100 mm2 and is limited
by the size of the probe that can be safely inserted. To irradiate
a larger area, one alternative approach uses miniature light-
emitting diodes (LEDs) wrapped around the eyeball,22 but
inhomogeneous light distribution, poor mechanical flexibility,
and risk of thermal damage to tissues caused by LED heat
generation limits their applicability.
Biomaterial waveguides with attractive properties such as
flexibility, biocompatibility, and efficient light delivery are
increasingly used to deliver light into tissues for biomedical
applications.23 In this study, we describe the development of
fiber-coupled, polymer waveguides for homogeneous peri-
scleral cross-linking. Our waveguides are well suited for
accessing the entire equatorial circumference owing to their
long light-delivery length (>7 cm), small thickness (<1.5 mm),
elasticity, and flexibility, while their optical properties are
optimized for efficient and homogeneous light delivery to
scleral tissue. Using riboflavin and blue light (445 nm), we
demonstrated SXL-induced stiffening of equatorial sclera
around the entire circumference of fresh porcine eyeballs.
METHODS
Elastomer Waveguide Fabrication
The waveguides were fabricated from polydimethylsiloxane
(PDMS) elastomer material (Sylgard 184; Dow Corning,
Midland, MI, USA). A base and curing solution was mixed at
10:1 ratio and added into a custom acrylic mold for preparing
elastomer sheets approximately 20 cm3 20 cm. The solution
was cured at room temperature for 48 hours, forming a solid,
flexible elastomer sheet. The elastomer sheet was then
wrapped in aluminum foil to facilitate cutting with a paper
trimmer. The thickness of the elastomer sheet was determined
by adjusting the total volume of solution used, and by inclining
the mold to fabricate linearly tapered waveguides. We
fabricated flat waveguides of thickness 0.8, 1.0, and 1.4 mm,
with a fabrication error of approximately 0.1 mm. Our tapered
waveguides had a thickness of 1.4 6 0.1 mm at the proximal
end, and a thickness of 0.5 6 0.1 mm at z = 75 6 5 mm. All of
the waveguides were cut to a width of 5 mm, and had a typical
length of 100 mm, of which ~70 to 80 mm was used to wrap
the eyeball for SXL.
Waveguide Optical Characterization
To measure the optical transmittance of the elastomer material,
the elastomer was cured in a 1-cm quartz cuvette. The
transmittance was measured by using an Evolution 300
spectrophotometer (Thermo Scientific, Waltham, MA, USA).
To quantify propagation loss, we coupled light into the
elastomer waveguide by using a multimode fiber with a
numerical aperture of 0.22 (Thorlabs, Newton, NJ, USA). The
fiber was coupled to a diode-pumped solid-state laser
delivering light at 445 nm (Civil Laser, Hangzhou, China).
The fiber was stripped of the acrylate coating, and 2 to 3 mm
of the bare fiber was inserted into the center of one end of an
elastomer waveguide. To measure the propagation loss of the
waveguides, the cut-back method was used. The transmitted
power through the waveguide was measured while the
waveguide was suspended in air, or placed on top of strips
of scleral tissue dissected from fresh porcine eyeballs. The
transmitted power through the waveguide was measured with
a double-integrating sphere (IS200-4; Thorlabs) at waveguide
lengths of 60, 45, 30, and 15 mm. The experiment was
repeated with at least three waveguides for each thickness
(0.8, 1.0, and 1.4 mm). The data were adjusted to compensate
for material absorption and fit to an exponential decay model
(see theory below) to extract the scattering loss coefficients to
air and scleral tissue.
Waveguide Loss Model
A full derivation of this waveguide loss model is presented in
Supplementary Note S1. In this simplified model, we consider
waveguide propagation loss through three main mechanisms:
material absorption, bulk scattering loss, and scattering due to
surface roughness. The light intensity inside the waveguide
Iin zð Þ at position z along the length approximately follows an
exponential decay:
Iin zð Þ’ I0  e ascattþcð Þz ; ð1Þ
where c is a loss coefficient due to material absorption, and
ascatt is a scattering coefficient describing total scattering loss
(bulk þ surface) resulting in incomplete total internal
reflection.
Light extracted from the waveguide Iext zð Þ per unit length is
described by:
Iext zð Þ’ ascattðzÞ  Iin zð Þ: ð2Þ
To compensate for the exponential attenuation in light
delivery, one solution is to design the waveguide by varying the
scattering cross-section ascatt as a function of z. For uniform
light delivery, we require dIext
dz
¼ 0. For our waveguides,
c  ascatt and Iin.0, this condition is achieved with the
following expression24 for ascatt:
ascattðzÞ’ 1
C  z ; ð3Þ
where C ¼ 1=ascattð0Þ.
The scattering cross-section is inversely proportional to the
thickness t of the waveguide, since the number of reflections
per unit length increases with decreasing thickness.
ascatt zð Þ ¼ A
t zð Þ ð4Þ
From Equations 3 and 4, the uniform delivery condition is
satisfied with a linear taper given by:
tðzÞ’ t0  Az; ð5Þ
where t0 is the initial waveguide thickness at z ¼ 0 and
A ¼ t0=C.
Fluorescence Measurements
Fresh adult porcine eyes were obtained within 2 hours
postmortem (Research 87, Inc., Boylston, MA, USA), and kept
on ice during transport and storage before starting experi-
ments. The whole eye was immersed in ~10 mL aqueous 0.5%
riboflavin-5-monophosphate (Sigma-Aldrich Corp., St. Louis,
MO, USA) for 30 minutes for staining. After staining, the eye
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was fixed on a rotational mount. For measurement of
fluorescence distribution, a flat or tapered waveguide was
wrapped around the eyeball equator. Blue light at low power
(<1 mW) was coupled into the waveguide. Images were taken
around the circumference of the eyeball by using a Nikon D90
camera (Nikon, Tokyo, Japan) with a 530 6 25 nm bandpass
emission filter (Edmund Optics, Barrington, NJ, USA) to collect
the riboflavin fluorescence profile. The uniformity of the
fluorescence distribution was quantified by the coefficient of
variation, which is defined as the standard deviation divided by
the mean light intensity along the waveguide. For photo-
bleaching experiments, the camera was focused to one region
of the sclera and images were taken every 30 seconds to
capture the change in riboflavin fluorescence over time. The
mean irradiance (measured in mW/cm2) delivered by the
waveguide was computed by measuring the input fiber power,
the coupling efficiency (typically 60%–70%), and the wave-
guide dimensions.
Scleral Cross-Linking
SXL experiments were performed by using linearly tapered
waveguides with thickness varying from 1.4 mm at the
proximal end to 0.5 mm in the distal end. For consistency,
the waveguides were wrapped around the eye equator such
that the proximal end of the waveguide touches the major axis
of the ellipsoid porcine cornea. The riboflavin-stained eyes
were irradiated with 0, 25, or 50 mW/cm2 for 30 minutes by
using the waveguides or with direct illumination without the
waveguide. At least six eyes were used for each condition. For
direct illumination, a blue light–emitting diode (M455F;
Thorlabs) was used as a light source and its divergent,
incoherent light centered at 455 nm was gently collimated
by a lens to a circular region of diameter ~15 mm in the
equatorial sclera (see Fig. 6B). A humidifier (Optimus,
Anaheim, CA, USA) was used to maintain scleral hydration
during the SXL procedure. Following SXL, the eye was lightly
labeled with a marker to indicate the location of the waveguide
on the sclera, including the proximal and distal ends.
Tensiometry
The eye was roughly divided into four quadrants, beginning
with the proximal end of the waveguide, and each measuring
approximately 908 between the two axes of the ellipsoid
porcine cornea. From the center of each quadrant, an anterior
to posterior scleral strip was excised by using two parallel
razor blades with a width of 4.9 mm. The retina was then
removed, and the thickness at the irradiated area was
determined by using a spring caliper. The sample was then
clamped horizontally at a distance of 2.4 mm in anterior to
posterior orientation between the two jaws of the tensiom-
eter (Admet, Norwood, MA, USA). To expose the tissue to the
physiological stress range as well as to establish the same
initial conditions, a force of 30 mN was applied for 5 seconds.
Afterwards in a second cycle, the force was reduced to 10
mN, at which the distance between the jaws was determined
as the initial length (i.e., zero strain). After reaching 10 mN,
the strain was increased linearly with a velocity of 0.017 mm/
s and the force was measured every 10 ms until a force of 8 N
was detected. Stress was calculated by dividing the force at a
certain strain by the cross-section area of the sample
(thickness obtained from caliper multiplied by width of 4.9
mm).
Statistics
Data were presented as mean 6 standard deviation, unless
otherwise stated. To assess differences between groups, two-
tailed, unpaired Student’s t-test was performed with signifi-
cance set at P < 0.05.
RESULTS
Waveguide Optical Characterization and Modeling
To achieve efficient light propagation inside the waveguide
(Fig. 1A), the waveguide should have an effective refractive
index higher than scleral tissue, which has a refractive index of
»1.38. We fabricated flexible polymer waveguides by using
PDMS elastomer, which has a refractive index of »1.42. To
couple light into the waveguide, we used an input pigtail fiber
with a numerical aperture of 0.22, which corresponds to
incident angles above the critical angle (hC), enabling total
internal reflection at either interface. The coupling efficiency
of the fiber into the waveguide typically ranged between 60%
and 70%. An image of the pigtail fiber–coupled waveguide is
shown in Figure 1B. Typically, the dimensions of the
waveguides were approximately 75 mm 3 5 mm 3 1 mm.
The waveguides are highly transparent in the visible and near
infrared wavelengths (400–800 nm), above 95% transmittance
per centimeter (Fig. 2A). We measured the propagation loss of
the waveguides while suspended in air and on excised scleral
tissue for flat waveguides of different thicknesses. As expected,
waveguide loss is inversely dependent on thickness (Fig. 2B).
Fitting to Equation 1 yielded a scattering loss coefficient to air,
aair of (4.4 6 0.2) 3 103 mm1, and a scattering loss
coefficient to scleral tissue, asclera of (5.9 6 0.4)3 103 mm1.
The waveguides had significantly higher loss to scleral tissue
than to air (P < 0.05).
One strategy for compensating the exponential attenuation
of light due to scattering loss is to taper the waveguide
thickness. This waveguide geometry ensures fewer reflections
toward the proximal end of the waveguide, where the
FIGURE 1. Elastomer waveguide schematic and optical characterization. (A) Schematic of the waveguide. Input light is delivered by an optical fiber
(blue line) to the slab waveguide with effective refractive index nwg. Optical rays greater than the critical angle <hC are guided via total internal
reflection. In this case, part of the light is extracted to tissue primarily through surface scattering (red arrows). (B) Images of the flexible waveguide
with coupled blue light through an input optical fiber.
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thickness is larger, and more reflections toward the distal end
where the thickness is smaller (Fig. 3A). Assuming absorption
is much less than scattering loss, a linear taper ensures near-
uniform light delivery (Equation 5). The light delivery profile
into scleral tissue was simulated with Equation S9, using the
empirically determined absorption and scattering loss coeffi-
cients (Fig. 3B). Increasing the tapering angle improves
uniformity of light delivery for linearly tapered waveguides
with t0 ¼ 1.4 mm until the thickness at the distal end is
approximately 0.34 mm, at which point the tapering effect
exceeds loss due to scattering and absorption.
Fluorescence Measurements on Riboflavin-Stained
Eyes
To validate our theoretical results, we measured the fluores-
cence distribution from 0.5% riboflavin-stained porcine eyes by
using waveguides wrapped around the equatorial sclera, and
coupled 445-nm excitation light (Fig. 4A). The measured
fluorescence profile around the eye is proportional to the
excitation light extracted from the waveguide to the scleral
tissue. We compared fluorescence profiles for flat and tapered
waveguides (Fig. 4B). The profile for 1-mm-thick flat elasto-
mers was fit to Equation 2, yielding a loss coefficient of 0.012
6 0.001 mm1, in agreement with our previous measurement
of propagation loss (Fig. 2B), which gave aair þ asclera¼ 0.0103
6 0.0004 mm1. When using tapered waveguides with a
thickness of 1.4 to 0.5 mm, the fluorescence profile became
more uniform, with a coefficient of variation of 9.9%,
compared to 27.8% for the flat waveguides.
To verify the excitation of riboflavin in the sclera, we
irradiated porcine eyes with mean irradiances of 25, 50, or 100
mW/cm2 (Fig. 5) and monitored photobleaching-induced
changes of riboflavin fluorescence during irradiation. We
found that 25 mW/cm2 was sufficient to bleach ~75% of the
riboflavin fluorescence in 30 minutes.
Periscleral Cross-Linking
We performed SXL by using 445-nm light at irradiances of 0,
25, and 50 mW/cm2 for 30 minutes on equatorial sclera around
the entire circumference of the porcine eye. The efficacy of
SXL-induced stiffening using the waveguides was compared
with direct laser illumination of a single region (Fig. 6A). Stress-
strain curves were obtained for excised scleral strips by using
conventional tensiometry. Figure 6B shows there is no
significant difference in stiffness when using the waveguide
and direct illumination at the same mean light irradiance. The
Young’s modulus at 8% strain was 5.9 6 0.5 MPa for
nonirradiated sclera (Fig. 6B). SXL treatment at 25 mW/cm2
resulted in a modulus of 9.5 6 2.0 MPa for sclera treated with
direct illumination, and 10.9 6 1.2 MPa for sclera treated with
waveguides. At 50 mW/cm2, the modulus was 10.2 6 1.9 MPa
for direct illumination, and 10.7 6 1.0 MPa with waveguides.
SXL treatment in all cases resulted in an approximately 1.8-fold
increase in the Young’s modulus as compared to control eyes
(P < 0.001). There was no significant difference in the Young’s
modulus for direct or waveguide-illuminated samples at either
irradiance (P > 0.05). With the elastomer waveguide, there
was no significant difference in stiffness between the
proximally and distally treated halves of the sclera (P ¼ 0.28
for 25 mW/cm2, P ¼ 0.62 for 50 mW/cm2).
DISCUSSION
In this study, we developed a novel approach to SXL by using
flexible PDMS waveguides optimized for efficient and uniform
light delivery to scleral tissue. The high optical transparency of
FIGURE 2. Optical characterization of the waveguides. (A) Optical
transmittance of the waveguide measured in quartz cuvette. (B) Loss
coefficient (a) to air and scleral tissue for flat waveguides of different
thicknesses. Data are fit to a ~ 1/t, showing that higher loss is
achieved with thinner waveguides. The predicted propagation loss is
0.0044 mm1 to air, and 0.0059 mm1 to sclera, for a total loss of
0.0103 mm1.
FIGURE 3. Tapering waveguides improve light uniformity. (A) Sche-
matic of a tapered waveguide showing fewer reflections near the
proximal end and more reflections near the distal end, compared to a
waveguide of constant thickness. (B) Simulation of the light delivery
profile along z for waveguides of different linear tapering. Waveguides
of initial thickness of 1.4 mm at z¼0 were simulated by using Equation
S9. Near-uniform light delivery is achieved for a waveguide with ~0.34-
mm thickness at z¼ 80 mm.
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our waveguides (Fig. 2A) is well suited for SXL, since
absorption-induced heat generation is minimal, in contrast to
heat-generating active optical devices such as LEDs. Any
wavelength in the visible to near-infrared region (400–800
nm) may also be used with the waveguides. For instance, Rose
Bengal excitation using 532-nm green light is an alternative
approach that could offer a different safety profile compared to
that of riboflavin.25 An attractive property of PDMS waveguides
is their hydrophobic external surface, which prevents ribofla-
vin diffusion into the waveguide throughout the procedure
that may take at least 30 minutes.
Light leakage from the waveguides is achieved through bulk
scattering inside the waveguide, and scattering due to surface
roughness of the waveguide–sclera interface, and the wave-
guide–air interface. We found that light delivery to sclera was
approximately 34% higher than to air, which is likely attributed
to the higher surface roughness of the tissue (Fig. 2B). Another
source of optical loss is radiation loss due to bending of the
waveguide, which alters the total internal reflection angles.
This effect was not significant in our study owing to the large
radius of curvature of porcine or human eyes (R ~ 12 mm)
compared to the waveguide thickness (t ~ 1 mm). The outer
surface of the waveguide is surrounded by air, which has a
much lower refractive index (n ¼ 1.0) than PDMS (n ¼ 1.42).
Experimentally, we indeed observed similar overall propaga-
tion loss when the waveguide was placed flat on excised
scleral strips (Fig. 2B) and when the waveguide was wrapped
around the eye (Fig. 4B). In clinical practice, the waveguide is
inserted into the extraocular socket and its external surface
will be in contact with Tenon’s capsule (with n ~ 1.38). To
minimize optical loss to surrounding tissues, a reflective layer
can be added to the outer surface of the waveguide, and a
second, thinner layer of PDMS on top of that, ensuring tissue
contacts only PDMS.
An important specification of our tapered waveguide design
is the uniform light delivery profile into the sclera over the
entire circumference, which has not been achieved in previous
SXL experiments that target select regions of the sclera. As the
rigid, outer layer of the eye, the sclera functions by resisting
intraocular forces to maintain a fixed eye shape such that a
stable retina image can be formed.19 The sclera is also capable
of undergoing matrix remodeling during normal growth, as
well as pathologic myopia, resulting in axial elongation. While
scleral stiffening with SXL may prevent axial elongation,
uneven stiffening may cause significant tensions on the retina
and probably transient astigmatism. For example, asymmetric
placement of scleral buckles during retinal detachment surgery
has induced transient astigmatic changes for at least 6 months
following surgery.26 In our study, we demonstrated significant-
ly improved light uniformity by linearly tapering the waveguide
thickness (Fig. 3). We achieved a variation in delivered light
intensity of less than 10%, which may be further improved by
increasing the tapering angle (Fig. 4). We also observed no
statistically significant difference in the proximally and distally
treated halves of the sclera as measured by tensiometry (Fig.
6B), suggesting light delivery is sufficiently uniform for whole-
globe SXL. Another approach to improve the uniformity of
light delivery would be to use two pigtail fibers to couple light
into the waveguide from both sides (Supplementary Note S2).
This approach is less attractive in practice, requiring fiber
insertion and optimization of fiber–waveguide coupling at one
end of the waveguide after it is wrapped around the eye.
Before SXL can be adopted in the clinic, risk of toxicities
caused by riboflavin and light irradiation to ocular tissues must
be considered. Using 450-nm blue light, a damage threshold of
200 to 400 mW/cm2 for 20 minutes has been established for
rabbit sclera.21,27 In our study, we used 25 to 50 mW/cm2
irradiation for 30 minutes, much lower than the damage
threshold, and yet achieved an increase of greater than 80% in
the Young’s modulus at 8% strain. SXL-induced changes in
elastic moduli can depend greatly on sample preparation and
analysis procedure, but our results are generally consistent
with previous studies using riboflavin and porcine eyes.17,28,29
FIGURE 4. Experimental validation using tapered waveguides. (A) Measurement of fluorescence intensity around a riboflavin-stained eyeball, using
coupled 445-nm light for excitation. (B) Fitting of light delivery profile for flat waveguides to Equation 2 (dotted blue line) yielding ascatt ¼ 0.012
mm1. Predicted light delivery profile for tapered waveguide, using Equation 8 (dotted red line). Tapered waveguides show significantly more
homogeneous light delivery than flat waveguides of similar mean thickness.
FIGURE 5. Photobleaching of riboflavin-stained sclera. Left: Images of
porcine eyeballs during (top) and after (bottom) SXL with blue light.
Bottom image shows pattern of bleached riboflavin along the equator
after 30 minutes of irradiation. Right: Photobleaching of riboflavin,
using mean irradiances of 13 to 50 mW/cm2.
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Light penetration into scleral tissue is limited by its high optical
scattering properties; at 445 nm, the scattering coefficient30 is
~80 cm1. Factoring in riboflavin absorption (~135 cm1 at
0.5% concentration), we anticipate cross-linking of less than
100 lm of scleral tissue in depth, much less than the full
thickness (>350 lm).31 Thus, our technique is unlikely to be
affected by the variations in scleral thickness around the eye.
Despite this limited therapeutic depth, we still achieved
significant increases in overall scleral stiffness, measured by
tensiometry. Of note, blue light is considered to be more
efficacious than UV-A light for riboflavin-based SXL owing to its
higher transmissivity and deeper penetration in tissue.32
Preferential absorption of blue light over UV-A light by the
choroid may also act as a barrier preventing retinal damage.29
Biomechanical Brillouin imaging may be used to quantitatively
assess the therapeutic depth of our technique, as well as
validate the uniformity of stiffening around the sclera.33,34
As a proof of principle for inhibition of axial elongation, we
chose to target equatorial sclera, which along with the
posterior pole, are the most weakened scleral regions in
myopia.16,19 Similar reductions in both the number of cross-
links35 and extracellular matrix protein accumulation36 in the
equatorial and posterior regions of myopic sclera suggest SXL
of either region may improve mechanical stability. Our flexible
waveguides could also be used to access the posterior pole,
which is more dramatically affected in later stages of myopia,
typically resulting in significant thinning.37,38 However, SXL of
the posterior pole carries significant risk of phototoxicities to
the retina and optic nerve, as well as the need for more
invasive surgery to expose the posterior sclera. Furthermore,
we anticipate SXL to be a prophylactic treatment for young, at-
risk patients with high myopia before they develop severe
consequences such as posterior staphyloma, which is more
common in older patients (e.g., 50 years or older).39
To target the equator in vivo, our flexible waveguides may
be safely inserted in Tenon’s space underneath the rectus
muscles, and wrapped around the eyeball. The surgical
technique to enforce the equator is already clinically approved,
for example, the cerclage technique for retinal detachment.
Previously described SXL approaches use either a UV-A lamp,40
a fiber-optic probe,13,14 or a dental blue light source connected
to plastic tubing12,21 to deliver light to scleral tissue. Not only
do these approaches provide uneven illumination by treating
only a few target regions of the eye, but also the illumination
area is relatively small owing to the limited probe size, typically
covering an area of 10 to 100 mm2. To treat the entire
equatorial surface, the eyeball needs to be manually rotated to
expose scleral tissue for optical access. Our waveguide
approach enables simultaneous treatment of the entire
circumference of the eye, improving treatment repeatability,
and shortening overall procedure times significantly. Thirty
minutes of light irradiation in our study was sufficient to cross-
link an area spanning 753 5 mm, which can be easily adjusted
depending on in vivo requirements. The significantly larger
tissue volume that is cross-linked by our method could
potentially have greater effects in halting axial growth of the
eye. Another advantage of our technique over other methods
of light delivery is the mechanical properties of our
waveguides. Compared to harder, more rigid devices such as
LEDs, or conventional fiber-optic probes to contact sclera,
there is less risk of tissue trauma when using our thin, soft, and
flexible PDMS-based waveguides.
In summary, periscleral cross-linking using flexible polymer
waveguides can be used to stiffen scleral tissue with similar
power efficacy as direct laser illumination. Our method
provides several important advantages for clinical translation,
including uniform light delivery, less invasive access to scleral
tissue, and efficient cross-linking of a large area. In vivo studies
are needed to demonstrate the safety of our method, as well as
its long-term efficacy in inhibiting axial length elongation
during myopia progression.
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